{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:01:39Z","timestamp":1783296099742,"version":"3.54.6"},"reference-count":135,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T00:00:00Z","timestamp":1763164800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T00:00:00Z","timestamp":1763164800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82373585"],"award-info":[{"award-number":["82373585"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100002858","name":"the China Postdoctoral Science Foundation","doi-asserted-by":"crossref","award":["2023M741364"],"award-info":[{"award-number":["2023M741364"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"crossref"}]},{"name":"the Natural Science Foundation of Shandong Province","award":["ZR2022MH007"],"award-info":[{"award-number":["ZR2022MH007"]}]},{"name":"the Jining Key R&D Projects","award":["2022YXNS124"],"award-info":[{"award-number":["2022YXNS124"]}]},{"name":"the Jining Key R&D Projects","award":["2022YXNS137"],"award-info":[{"award-number":["2022YXNS137"]}]},{"name":"the Medical and Health Science and Technology Development Project of Shandong Province","award":["202304040457"],"award-info":[{"award-number":["202304040457"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Neurobiol"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1007\/s12035-025-05364-9","type":"journal-article","created":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T03:41:39Z","timestamp":1763178099000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Mechanisms and Clinical Significance of Endosomal Toll-Like Receptors in Neurological Diseases"],"prefix":"10.1007","volume":"63","author":[{"given":"Weihua","family":"Kong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinglu","family":"Miao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruili","family":"Dang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,15]]},"reference":[{"key":"5364_CR1","unstructured":"GBD 2021 Nervous System Disorders Collaborators (2024) Global, regional, and national burden of disorders affecting the nervous system, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol 23(4):344\u2013381"},{"key":"5364_CR2","unstructured":"GBD 2019 Dementia Forecasting Collaborators (2022) Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the Global Burden of Disease Study 2019. Lancet Public Health 7(2):105\u2013125"},{"issue":"1","key":"5364_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1001\/jamaneurol.2017.3299","volume":"75","author":"ER Dorsey","year":"2018","unstructured":"Dorsey ER, Bloem BR (2018) The Parkinson pandemic-a call to action. JAMA Neurol 75(1):9\u201310","journal-title":"JAMA Neurol"},{"issue":"6","key":"5364_CR4","doi-asserted-by":"publisher","first-page":"927","DOI":"10.1016\/j.immuni.2017.06.008","volume":"46","author":"SS Chavan","year":"2017","unstructured":"Chavan SS, Pavlov VA, Tracey KJ (2017) Mechanisms and therapeutic relevance of neuro-immune communication. Immunity 46(6):927\u2013942","journal-title":"Immunity"},{"key":"5364_CR5","doi-asserted-by":"crossref","unstructured":"Moresco EM, LaVine D, Beutler B (2011) Toll-like receptors. Curr Biol 21(13):488\u2013493","DOI":"10.1016\/j.cub.2011.05.039"},{"issue":"5","key":"5364_CR6","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.immuni.2011.05.006","volume":"34","author":"T Kawai","year":"2011","unstructured":"Kawai T, Akira S (2011) Toll-like receptors and their crosstalk with other innate receptors in infection and immunity. Immunity 34(5):637\u2013650","journal-title":"Immunity"},{"issue":"2","key":"5364_CR7","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1042\/BJ20131492","volume":"458","author":"M Tatematsu","year":"2014","unstructured":"Tatematsu M, Seya T, Matsumoto M (2014) Beyond dsRNA: Toll-like receptor 3 signalling in RNA-induced immune responses. Biochem J 458(2):195\u2013201","journal-title":"Biochem J"},{"issue":"11","key":"5364_CR8","doi-asserted-by":"publisher","first-page":"12500","DOI":"10.1096\/fj.201901547R","volume":"33","author":"NS Khan","year":"2019","unstructured":"Khan NS, Lukason DP, Feliu M, Ward RA, Lord AK, Reedy JL et al (2019) CD82 controls CpG-dependent TLR9 signaling. FASEB J 33(11):12500\u201312514","journal-title":"FASEB J"},{"key":"5364_CR9","doi-asserted-by":"crossref","unstructured":"Heil F, Hemmi H, Hochrein H, Ampenberger F, Kirschning C, Akira S, Lipford G, Wagner H, Bauer S\u00a0(2004) Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303(5663):1526\u20131529","DOI":"10.1126\/science.1093620"},{"key":"5364_CR10","doi-asserted-by":"crossref","unstructured":"Li Z, Okamoto K, Hayashi Y, Sheng M (2004) The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses. Cell 119(6):873\u2013887","DOI":"10.1016\/j.cell.2004.11.003"},{"issue":"4","key":"5364_CR11","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1007\/s12264-014-1445-5","volume":"30","author":"HY Liu","year":"2014","unstructured":"Liu HY, Chen CY, Hsueh YP (2014) Innate immune responses regulate morphogenesis and degeneration: roles of toll-like receptors and Sarm1 in neurons. Neurosci Bull 30(4):645\u2013654","journal-title":"Neurosci Bull"},{"issue":"3","key":"5364_CR12","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1080\/13550280600848399","volume":"12","author":"AC Jackson","year":"2006","unstructured":"Jackson AC, Rossiter JP, Lafon M (2006) Expression of Toll-like receptor 3 in the human cerebellar cortex in rabies, herpes simplex encephalitis, and other neurological diseases. J Neurovirol 12(3):229\u2013234","journal-title":"J Neurovirol"},{"issue":"35","key":"5364_CR13","doi-asserted-by":"publisher","first-page":"15625","DOI":"10.1073\/pnas.1005807107","volume":"107","author":"E Okun","year":"2010","unstructured":"Okun E, Griffioen K, Barak B, Roberts NJ, Castro K, Pita MA et al (2010) Toll-like receptor 3 inhibits memory retention and constrains adult hippocampal neurogenesis. Proc Natl Acad Sci USA 107(35):15625\u201315630","journal-title":"Proc Natl Acad Sci USA"},{"issue":"47","key":"5364_CR14","doi-asserted-by":"publisher","first-page":"13033","DOI":"10.1523\/JNEUROSCI.4290-06.2007","volume":"27","author":"JS Cameron","year":"2007","unstructured":"Cameron JS, Alexopoulou L, Sloane JA, DiBernardo AB, Ma Y, Kosaras B et al (2007) Toll-like receptor 3 is a potent negative regulator of axonal growth in mammals. J Neurosci 27(47):13033\u201313041","journal-title":"J Neurosci"},{"issue":"8","key":"5364_CR15","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.1111\/cns.13851","volume":"28","author":"ZA Khan","year":"2022","unstructured":"Khan ZA, Sumsuzzman DM, Choi J, Kamenos G, Hong Y (2022) Pre- and post-conditioning with poly I:C exerts neuroprotective effect against cerebral ischemia injury in animal models: a systematic review and meta-analysis. CNS Neurosci Ther 28(8):1168\u20131182","journal-title":"CNS Neurosci Ther"},{"key":"5364_CR16","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.bbi.2019.09.004","volume":"82","author":"KA Michaelis","year":"2019","unstructured":"Michaelis KA, Norgard MA, Levasseur PR, Olson B, Burfeind KG, Buenafe AC et al (2019) Persistent toll-like receptor 7 stimulation induces behavioral and molecular innate immune tolerance. Brain Behav Immun 82:338\u2013353","journal-title":"Brain Behav Immun"},{"issue":"11","key":"5364_CR17","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1111\/cns.13919","volume":"28","author":"J Wei","year":"2022","unstructured":"Wei J, Dai S, Pu C, Luo P, Yang Y, Jiang X et al (2022) Protective role of TLR9-induced macrophage\/microglia phagocytosis after experimental intracerebral hemorrhage in mice. CNS Neurosci Ther 28(11):1800\u20131813","journal-title":"CNS Neurosci Ther"},{"issue":"4","key":"5364_CR18","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.4049\/jimmunol.0902592","volume":"184","author":"KM Nickerson","year":"2010","unstructured":"Nickerson KM, Christensen SR, Shupe J, Kashgarian M, Kim D, Elkon K et al (2010) TLR9 regulates TLR7- and MyD88-dependent autoantibody production and disease in a murine model of lupus. J Immunol 184(4):1840\u20131848","journal-title":"J Immunol"},{"key":"5364_CR19","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/787023","volume":"2014","author":"R Jiang","year":"2014","unstructured":"Jiang R, Ye J, Zhu B, Song Y, Chen H, Cao S (2014) Roles of TLR3 and RIG-I in mediating the inflammatory response in mouse microglia following Japanese encephalitis virus infection. J Immunol Res 2014:787023","journal-title":"J Immunol Res"},{"issue":"2","key":"5364_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03446-9","volume":"12","author":"M Boccazzi","year":"2021","unstructured":"Boccazzi M, Van Steenwinckel J, Schang AL, Faivre V, Le Charpentier T, Bokobza C et al (2021) The immune-inflammatory response of oligodendrocytes in a murine model of preterm white matter injury: the role of TLR3 activation. Cell Death Dis 12(2):166","journal-title":"Cell Death Dis"},{"key":"5364_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/1742-2094-8-178","volume":"8","author":"YH Jin","year":"2011","unstructured":"Jin YH, Kaneyama T, Kang MH, Kang HS, Koh CS, Kim BS (2011) TLR3 signaling is either protective or pathogenic for the development of Theiler. J Neuroinflammation 8:178","journal-title":"J Neuroinflammation"},{"issue":"7","key":"5364_CR22","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1002\/glia.20328","volume":"53","author":"M Bsibsi","year":"2006","unstructured":"Bsibsi M, Persoon-Deen C, Verwer RW, Meeuwsen S, Ravid R, Van Noort JM (2006) Toll-like receptor 3 on adult human astrocytes triggers production of neuroprotective mediators. Glia 53(7):688\u2013695","journal-title":"Glia"},{"key":"5364_CR23","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1016\/j.bbi.2019.04.010","volume":"80","author":"L Li","year":"2019","unstructured":"Li L, Ni L, Eugenin EA, Heary RF, Elkabes S (2019) Toll-like receptor 9 antagonism modulates astrocyte function and preserves proximal axons following spinal cord injury. Brain Behav Immun 80:328\u2013343","journal-title":"Brain Behav Immun"},{"issue":"4","key":"5364_CR24","doi-asserted-by":"publisher","first-page":"447","DOI":"10.15252\/embr.201439637","volume":"16","author":"YH Hu","year":"2015","unstructured":"Hu YH, Zhang Y, Jiang LQ, Wang S, Lei CQ, Sun MS et al (2015) WDFY1 mediates TLR3\/4 signaling by recruiting TRIF. EMBO Rep 16(4):447\u2013455","journal-title":"EMBO Rep"},{"key":"5364_CR25","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00461","volume":"5","author":"T Kawasaki","year":"2014","unstructured":"Kawasaki T, Kawai T (2014) Toll-like receptor signaling pathways. Front Immunol 5:461","journal-title":"Front Immunol"},{"issue":"6813","key":"5364_CR26","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1038\/35047123","volume":"408","author":"H Hemmi","year":"2000","unstructured":"Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, Sanjo H et al (2000) A toll-like receptor recognizes bacterial DNA. Nature 408(6813):740\u2013745","journal-title":"Nature"},{"issue":"2","key":"5364_CR27","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1083\/jcb.201712011","volume":"218","author":"F Niu","year":"2019","unstructured":"Niu F, Liao K, Hu G, Sil S, Callen S, Guo ML et al (2019) Cocaine-induced release of CXCL10 from pericytes regulates monocyte transmigration into the CNS. J Cell Biol 218(2):700\u2013721","journal-title":"J Cell Biol"},{"issue":"8","key":"5364_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e29484","volume":"10","author":"S Hao","year":"2024","unstructured":"Hao S, Yuan S, Liu Z, Hou B, Feng S, Zhang D (2024) Neuroprotective effects of takinib on an experimental traumatic brain injury rat model via inhibition of transforming growth factor beta-activated kinase 1. Heliyon 10(8):e29484","journal-title":"Heliyon"},{"issue":"37","key":"5364_CR29","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2121385119","volume":"119","author":"S Popli","year":"2022","unstructured":"Popli S, Chakravarty S, Fan S, Glanz A, Aras S, Nagy LE et al (2022) IRF3 inhibits nuclear translocation of NF-\u03baB to prevent viral inflammation. Proc Natl Acad Sci USA 119(37):e2121385119","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"5364_CR30","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.immuni.2024.03.002","volume":"57","author":"M Ma","year":"2024","unstructured":"Ma M, Jiang W, Zhou R (2024) DAMPs and DAMP-sensing receptors in inflammation and diseases. Immunity 57(4):752\u2013771","journal-title":"Immunity"},{"key":"5364_CR31","doi-asserted-by":"crossref","unstructured":"Liu J, Ke P, Guo H, Gu J, Liu Y, Tian X, et al (2023) Activation of TLR7-mediated autophagy increases epileptic susceptibility via reduced KIF5A-dependent GABAA receptor transport in a murine model. Exp Mol Med EMM 55(6):1159\u20131173","DOI":"10.1038\/s12276-023-01000-5"},{"key":"5364_CR32","doi-asserted-by":"crossref","unstructured":"Cukovic D, Bagla S, Ukasik D, Stemmer PM, Jena BP, Naik AR et al (2021) Exosomes in epilepsy of tuberous sclerosis complex: carriers of pro-inflammatory microRNAs. Non-coding RNA 7(3):40","DOI":"10.3390\/ncrna7030040"},{"key":"5364_CR33","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1146\/annurev-neuro-070815-014015","volume":"39","author":"C Sala Frigerio","year":"2016","unstructured":"Sala Frigerio C, De Strooper B (2016) Alzheimer. Annu Rev Neurosci 39:57\u201379","journal-title":"Annu Rev Neurosci"},{"issue":"9\u201310","key":"5364_CR34","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1017\/S135561771700100X","volume":"23","author":"MW Bondi","year":"2017","unstructured":"Bondi MW, Edmonds EC, Salmon DP (2017) Alzheimer. J Int Neuropsychol Soc 23(9\u201310):818\u2013831","journal-title":"J Int Neuropsychol Soc"},{"key":"5364_CR35","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.clinbiochem.2019.04.001","volume":"72","author":"T Ozben","year":"2019","unstructured":"Ozben T, Ozben S (2019) Neuro-inflammation and anti-inflammatory treatment options for Alzheimer. Clin Biochem 72:87\u201389","journal-title":"Clin Biochem"},{"issue":"1","key":"5364_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-023-01186-w","volume":"15","author":"S Wang","year":"2023","unstructured":"Wang S, Zhu T, Ni W, Zhou C, Zhou H (2023) Early activation of Toll-like receptor-3 reduces the pathological progression of Alzheimer\u2019s disease in APP\/PS1 mouse. Alzheimers Res Ther 15(1):33","journal-title":"Alzheimers Res Ther"},{"key":"5364_CR37","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/j.bbi.2019.04.024","volume":"80","author":"C Chen","year":"2019","unstructured":"Chen C, Gao R, Li M, Wang Q, Chen H (2019) Extracellular RNAs-TLR3 signaling contributes to cognitive decline in a mouse model of postoperative cognitive dysfunction. Brain Behav Immun 80:439\u2013451","journal-title":"Brain Behav Immun"},{"key":"5364_CR38","doi-asserted-by":"crossref","unstructured":"Nessa BN, Tanaka T, Kamino K, Sadik G, Ansar AB, Kimura RYO et al (2006) Toll\u2010like receptor 3 mediated hyperphosphorylation of tau in human SH\u2010SY5Y neuroblastoma cells. PCN 60:27\u201333","DOI":"10.1111\/j.1440-1819.2006.01526.x-i1"},{"issue":"6","key":"5364_CR39","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1111\/jnc.15716","volume":"163","author":"N Yamamoto","year":"2022","unstructured":"Yamamoto N, Tokumon T, Obuchi A, Kono M, Saigo K, Tanida M et al (2022) Poly(I:C) promotes neurotoxic amyloid \u03b2 accumulation through reduced degradation by decreasing neprilysin protein levels in astrocytes. J Neurochem 163(6):517\u2013530","journal-title":"J Neurochem"},{"key":"5364_CR40","doi-asserted-by":"crossref","unstructured":"Walker DG, Tang TM, Serrano GE, Sue LI, Beach TG, Lue LF (2017) Increased expression of toll-like receptor (tlr)-3 in alzheimer\u2019s disease brain: a protective or pathogenic response? Alzheimer\u2019s & Dementia 13:1499","DOI":"10.1016\/j.jalz.2017.07.597"},{"issue":"35","key":"5364_CR41","doi-asserted-by":"publisher","first-page":"15625","DOI":"10.1073\/pnas.1005807107","volume":"107","author":"E Okun","year":"2010","unstructured":"Okun E, Griffioen K, Barak B, Roberts NJ, Castro K, Pita MA et al (2010) Toll-like receptor 3 inhibits memory retention and constrains adult hippocampal neurogenesis. Proc Natl Acad Sci U S A 107(35):15625\u201315630","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"5364_CR42","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nn.3113","volume":"15","author":"SM Lehmann","year":"2012","unstructured":"Lehmann SM, Kr\u00fcger C, Park B, Derkow K, Rosenberger K, Baumgart J et al (2012) An unconventional role for miRNA: let-7 activates Toll-like receptor 7 and causes neurodegeneration. Nat Neurosci 15(6):827\u2013835","journal-title":"Nat Neurosci"},{"issue":"7","key":"5364_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0200602","volume":"13","author":"K Derkow","year":"2018","unstructured":"Derkow K, R\u00f6ssling R, Schipke C, Kr\u00fcger C, Bauer J, F\u00e4hling M et al (2018) Distinct expression of the neurotoxic microRNA family let-7 in the cerebrospinal fluid of patients with Alzheimer. PLoS ONE 13(7):e0200602","journal-title":"PLoS ONE"},{"issue":"7","key":"5364_CR44","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1038\/emboj.2008.31","volume":"27","author":"MA Delgado","year":"2008","unstructured":"Delgado MA, Elmaoued RA, Davis AS, Kyei G, Deretic V (2008) Toll-like receptors control autophagy. EMBO J 27(7):1110\u20131121","journal-title":"EMBO J"},{"issue":"1","key":"5364_CR45","doi-asserted-by":"publisher","first-page":"16760","DOI":"10.1038\/s41598-017-16754-y","volume":"7","author":"F La Rosa","year":"2017","unstructured":"La Rosa F, Saresella M, Baglio F, Piancone F, Marventano I, Calabrese E et al (2017) Immune and imaging correlates of mild cognitive impairment conversion to Alzheimer. Sci Rep 7(1):16760","journal-title":"Sci Rep"},{"key":"5364_CR46","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.bbi.2015.04.014","volume":"49","author":"J Ni","year":"2015","unstructured":"Ni J, Wang X, Chen S, Liu H, Wang Y, Xu X et al (2015) Microrna let-7c-5p protects against cerebral ischemia injury via mechanisms involving the inhibition of microglia activation. Brain Behav Immun 49:75\u201385","journal-title":"Brain Behav Immun"},{"key":"5364_CR47","doi-asserted-by":"crossref","unstructured":"Scholtzova H, Goni F, Pan J, Sun Y, Li J, Mehta P et al (2012) Innate immunity stimulation as a novel therapeutic approach in Alzheimer\u2019s disease. Alzheimer\u2019s & Dementia 8:392","DOI":"10.1016\/j.jalz.2012.05.1078"},{"issue":"5","key":"5364_CR48","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.2353\/ajpath.2009.090418","volume":"175","author":"Y Doi","year":"2009","unstructured":"Doi Y, Mizuno T, Maki Y, Jin S, Mizoguchi H, Ikeyama M et al (2009) Microglia activated with the toll-like receptor 9 ligand CpG attenuate oligomeric amyloid beta neurotoxicity in in vitro and in vivo models of Alzheimer\u2019s disease. Am J Pathol 175(5):2121\u20132132","journal-title":"Am J Pathol"},{"issue":"5","key":"5364_CR49","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.2353\/ajpath.2009.090418","volume":"175","author":"Y Doi","year":"2009","unstructured":"Doi Y, Mizuno T, Maki Y, Jin S, Mizoguchi H, Ikeyama M et al (2009) Microglia activated with the toll-like receptor 9 ligand CpG attenuate oligomeric amyloid beta neurotoxicity in in vitro and in vivo models of Alzheimer. Am J Pathol 175(5):2121\u20132132","journal-title":"Am J Pathol"},{"key":"5364_CR50","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.jneuroim.2019.03.012","volume":"332","author":"V Kumar","year":"2019","unstructured":"Kumar V (2019) Toll-like receptors in the pathogenesis of neuroinflammation. J Neuroimmunol 332:16\u201330","journal-title":"J Neuroimmunol"},{"issue":"1","key":"5364_CR51","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1016\/j.neulet.2009.01.075","volume":"453","author":"S Frank","year":"2009","unstructured":"Frank S, Copanaki E, Burbach GJ, M\u00fcller UC, Deller T (2009) Differential regulation of toll-like receptor mRNAs in amyloid plaque-associated brain tissue of aged APP23 transgenic mice. Neurosci Lett 453(1):41\u201344","journal-title":"Neurosci Lett"},{"issue":"7","key":"5364_CR52","doi-asserted-by":"publisher","first-page":"2146","DOI":"10.1093\/brain\/awab129","volume":"144","author":"AG Patel","year":"2021","unstructured":"Patel AG, Nehete PN, Krivoshik SR, Pei X, Cho EL, Nehete BP et al (2021) Innate immunity stimulation via CpG oligodeoxynucleotides ameliorates Alzheimer. Brain 144(7):2146\u20132165","journal-title":"Brain"},{"issue":"6","key":"5364_CR53","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1523\/JNEUROSCI.5715-08.2009","volume":"29","author":"H Scholtzova","year":"2009","unstructured":"Scholtzova H, Kascsak RJ, Bates KA, Boutajangout A, Kerr DJ, Meeker HC et al (2009) Induction of toll-like receptor 9 signaling as a method for ameliorating Alzheimer\u2019s disease-related pathology. J Neurosci 29(6):1846\u20131854","journal-title":"J Neurosci"},{"key":"5364_CR54","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1093\/bmb\/ldn013","volume":"86","author":"CA Davie","year":"2008","unstructured":"Davie CA (2008) A review of Parkinson. Br Med Bull 86:109\u2013127","journal-title":"Br Med Bull"},{"key":"5364_CR55","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2020.135005","volume":"728","author":"J Wang","year":"2020","unstructured":"Wang J, Liu Y, Liu Y, Zhu K, Xie A (2020) The association between TLR3 rs3775290 polymorphism and sporadic Parkinson\u2019s disease in Chinese Han population. Neurosci Lett 728:135005","journal-title":"Neurosci Lett"},{"key":"5364_CR56","doi-asserted-by":"crossref","unstructured":"Chung YC, Jeong J, Jin BK (2018) TLR3 contributes to degeneration of dopamine neurons in an MPTP mouse model of Parkinson\u2019s disease. J Immunol 200:166.55","DOI":"10.4049\/jimmunol.200.Supp.166.55"},{"issue":"7","key":"5364_CR57","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.parkreldis.2014.02.031","volume":"20","author":"JM Woulfe","year":"2014","unstructured":"Woulfe JM, Gray MT, Gray DA, Munoz DG, Middeldorp JM (2014) Hypothesis: a role for EBV-induced molecular mimicry in Parkinson. Parkinsonism Relat Disord 20(7):685\u2013694","journal-title":"Parkinsonism Relat Disord"},{"issue":"7","key":"5364_CR58","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1111\/jvh.12517","volume":"23","author":"KJ Wangensteen","year":"2016","unstructured":"Wangensteen KJ, Krawitt EL, Hamill RW, Boyd JT (2016) Hepatitis C virus infection: a risk factor for Parkinson. J Viral Hepat 23(7):535","journal-title":"J Viral Hepat"},{"issue":"2","key":"5364_CR59","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1097\/QAI.0000000000000677","volume":"70","author":"A Moulignier","year":"2015","unstructured":"Moulignier A, Gueguen A, Lescure FX, Ziegler M, Girard PM, Cardon B et al (2015) Does HIV infection alter Parkinson disease? J Acquir Immune Defic Syndr 70(2):129\u2013136","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"24","key":"5364_CR60","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21249384","volume":"21","author":"M Campolo","year":"2020","unstructured":"Campolo M, Filippone A, Biondo C, Mancuso G, Casili G, Lanza M et al (2020) TLR7\/8 in the pathogenesis of Parkinson\u2019s disease. Int J Mol Sci 21(24):9384","journal-title":"Int J Mol Sci"},{"issue":"7","key":"5364_CR61","first-page":"612","volume":"126","author":"K Zhu","year":"2016","unstructured":"Zhu K, Teng J, Zhao J, Liu H, Xie A (2016) Association of TLR9 polymorphisms with sporadic Parkinson. Int J Neurosci 126(7):612\u2013616","journal-title":"Int J Neurosci"},{"issue":"2","key":"5364_CR62","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1096\/fj.03-0670fje","volume":"18","author":"AI Iliev","year":"2004","unstructured":"Iliev AI, Stringaris AK, Nau R, Neumann H (2004) Neuronal injury mediated via stimulation of microglial toll-like receptor-9 (TLR9). FASEB J 18(2):412\u2013414","journal-title":"FASEB J"},{"key":"5364_CR63","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-014-0166-7","volume":"11","author":"K Rosenberger","year":"2014","unstructured":"Rosenberger K, Derkow K, Dembny P, Kr\u00fcger C, Schott E, Lehnardt S (2014) The impact of single and pairwise toll-like receptor activation on neuroinflammation and neurodegeneration. J Neuroinflammation 11:166","journal-title":"J Neuroinflammation"},{"issue":"16","key":"5364_CR64","doi-asserted-by":"publisher","first-page":"6632","DOI":"10.1073\/pnas.1017820108","volume":"108","author":"F Ros-Bernal","year":"2011","unstructured":"Ros-Bernal F, Hunot S, Herrero MT, Parnadeau S, Corvol JC, Lu L et al (2011) Microglial glucocorticoid receptors play a pivotal role in regulating dopaminergic neurodegeneration in parkinsonism. Proc Natl Acad Sci USA 108(16):6632\u20136637","journal-title":"Proc Natl Acad Sci USA"},{"issue":"10","key":"5364_CR65","doi-asserted-by":"publisher","first-page":"1116","DOI":"10.1097\/NEN.0b013e3181b7fde5","volume":"68","author":"SC Tauber","year":"2009","unstructured":"Tauber SC, Ebert S, Weishaupt JH, Reich A, Nau R, Gerber J (2009) Stimulation of toll-like receptor 9 by chronic intraventricular unmethylated cytosine-guanine DNA infusion causes neuroinflammation and impaired spatial memory. J Neuropathol Exp Neurol 68(10):1116\u20131124","journal-title":"J Neuropathol Exp Neurol"},{"key":"5364_CR66","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.3389\/fimmu.2018.01240","volume":"9","author":"C D","year":"2018","unstructured":"D C, Angelo, Reale M, Costantini E, Di Nicola M, Porfilio I, de Andr\u00e9s C et al (2018) Profiling of canonical and non-traditional cytokine levels in interferon-\u03b2-treated relapsing-remitting-multiple sclerosis patients. Front Immunol 9:1240","journal-title":"Front Immunol"},{"issue":"11","key":"5364_CR67","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1093\/jnen\/61.11.1013","volume":"61","author":"M Bsibsi","year":"2002","unstructured":"Bsibsi M, Ravid R, Gveric D, van Noort JM (2002) Broad expression of toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol 61(11):1013\u20131021","journal-title":"J Neuropathol Exp Neurol"},{"issue":"11","key":"5364_CR68","doi-asserted-by":"publisher","first-page":"7505","DOI":"10.4049\/jimmunol.177.11.7505","volume":"177","author":"T Touil","year":"2006","unstructured":"Touil T, Fitzgerald D, Zhang GX, Rostami A, Gran B (2006) Cutting edge: TLR3 stimulation suppresses experimental autoimmune encephalomyelitis by inducing endogenous IFN-beta. J Immunol 177(11):7505\u20137509","journal-title":"J Immunol"},{"issue":"12","key":"5364_CR69","doi-asserted-by":"publisher","first-page":"6929","DOI":"10.4049\/jimmunol.0902419","volume":"184","author":"M Bsibsi","year":"2010","unstructured":"Bsibsi M, Bajramovic JJ, Vogt MH, van Duijvenvoorden E, Baghat A, Persoon-Deen C et al (2010) The microtubule regulator stathmin is an endogenous protein agonist for TLR3. J Immunol 184(12):6929\u20136937","journal-title":"J Immunol"},{"issue":"47","key":"5364_CR70","doi-asserted-by":"publisher","first-page":"14965","DOI":"10.1523\/JNEUROSCI.3794-09.2009","volume":"29","author":"AM Soulika","year":"2009","unstructured":"Soulika AM, Lee E, McCauley E, Miers L, Bannerman P, Pleasure D (2009) Initiation and progression of axonopathy in experimental autoimmune encephalomyelitis. J Neurosci 29(47):14965\u201314979","journal-title":"J Neurosci"},{"issue":"6","key":"5364_CR71","doi-asserted-by":"publisher","first-page":"3928","DOI":"10.4049\/jimmunol.0802226","volume":"182","author":"X Zhang","year":"2009","unstructured":"Zhang X, Jin J, Tang Y, Speer D, Sujkowska D, Markovic-Plese S (2009) IFN-beta1a inhibits the secretion of Th17-polarizing cytokines in human dendritic cells via TLR7 up-regulation. J Immunol 182(6):3928\u20133936","journal-title":"J Immunol"},{"issue":"1\u20132","key":"5364_CR72","first-page":"107","volume":"221","author":"K O","year":"2010","unstructured":"O K, Brien, Fitzgerald D, Rostami A, Gran B (2010) The TLR7 agonist, imiquimod, increases IFN-beta production and reduces the severity of experimental autoimmune encephalomyelitis. J Neuroimmunol 221(1\u20132):107\u2013111","journal-title":"J Neuroimmunol"},{"issue":"3","key":"5364_CR73","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0058808","volume":"8","author":"B Li","year":"2013","unstructured":"Li B, Baylink DJ, Deb C, Zannetti C, Rajaallah F, Xing W et al (2013) 1,25-dihydroxyvitamin D3 suppresses TLR8 expression and TLR8-mediated inflammatory responses in monocytes in vitro and experimental autoimmune encephalomyelitis in vivo. PLoS One 8(3):e58808","journal-title":"PLoS One"},{"issue":"5","key":"5364_CR74","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.4049\/jimmunol.169.5.2781","volume":"169","author":"HT Ichikawa","year":"2002","unstructured":"Ichikawa HT, Williams LP, Segal BM (2002) Activation of APCs through CD40 or toll-like receptor 9 overcomes tolerance and precipitates autoimmune disease. J Immunol 169(5):2781\u20132787","journal-title":"J Immunol"},{"issue":"6","key":"5364_CR75","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1002\/ana.22136","volume":"68","author":"KE Balashov","year":"2010","unstructured":"Balashov KE, Aung LL, Vaknin-Dembinsky A, Dhib-Jalbut S, Weiner HL (2010) Interferon-\u03b2 inhibits toll-like receptor 9 processing in multiple sclerosis. Ann Neurol 68(6):899\u2013906","journal-title":"Ann Neurol"},{"issue":"2","key":"5364_CR76","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1172\/JCI26078","volume":"116","author":"M Prinz","year":"2006","unstructured":"Prinz M, Garbe F, Schmidt H, Mildner A, Gutcher I, Wolter K et al (2006) Innate immunity mediated by TLR9 modulates pathogenicity in an animal model of multiple sclerosis. J Clin Invest 116(2):456\u2013464","journal-title":"J Clin Invest"},{"issue":"3","key":"5364_CR77","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1073\/pnas.1109173109","volume":"109","author":"K Miles","year":"2012","unstructured":"Miles K, Heaney J, Sibinska Z, Salter D, Savill J, Gray D et al (2012) A tolerogenic role for Toll-like receptor 9 is revealed by B-cell interaction with DNA complexes expressed on apoptotic cells. Proc Natl Acad Sci U S A 109(3):887\u2013892","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"5364_CR78","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11707-7","volume":"10","author":"EJ Bradbury","year":"2019","unstructured":"Bradbury EJ, Burnside ER (2019) Moving beyond the glial scar for spinal cord repair. Nat Commun 10(1):3879","journal-title":"Nat Commun"},{"issue":"10","key":"5364_CR79","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.115.002440","volume":"4","author":"D Lobenwein","year":"2015","unstructured":"Lobenwein D, Tepekoylu C, Kozaryn R, Pechriggl EJ, Bitsche M, Graber M et al (2015) Shock wave treatment protects from neuronal degeneration via a toll-like receptor 3 dependent mechanism: implications of a first-ever causal treatment for ischemic spinal cord injury. J Am Heart Assoc 4(10):e002440","journal-title":"J Am Heart Assoc"},{"key":"5364_CR80","doi-asserted-by":"crossref","unstructured":"Lobenwein D, Huber R, Kerbler L, Gratl A, Wipper S, Gollmann-Tepek\u00f6yl\u00fc C et al (2022) Neuronal pre- and postconditioning via Toll-like receptor 3 agonist or extracorporeal shock wave therapy as new treatment strategies for spinal cord ischemia: an in vitro study. J Clin Med\u00a011(8):2115","DOI":"10.3390\/jcm11082115"},{"key":"5364_CR81","doi-asserted-by":"crossref","unstructured":"Gollmann-Tepek\u00f6yl\u00fc C, N\u00e4gele F, Graber M, P\u00f6lzl L, Lobenwein D, Hirsch J et al (2020) Shock waves promote spinal cord repair via TLR3. JCI Insight\u00a05(15):e134552","DOI":"10.1172\/jci.insight.134552"},{"issue":"1","key":"5364_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-017-0977-4","volume":"14","author":"XQ Li","year":"2017","unstructured":"Li XQ, Chen FS, Tan WF, Fang B, Zhang ZL, Ma H (2017) Elevated microRNA-129-5p level ameliorates neuroinflammation and blood-spinal cord barrier damage after ischemia-reperfusion by inhibiting HMGB1 and the TLR3-cytokine pathway. J Neuroinflammation 14(1):205","journal-title":"J Neuroinflammation"},{"key":"5364_CR83","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.bbi.2016.03.027","volume":"56","author":"C Acioglu","year":"2016","unstructured":"Acioglu C, Mirabelli E, Baykal AT, Ni L, Ratnayake A, Heary RF et al (2016) Toll like receptor 9 antagonism modulates spinal cord neuronal function and survival: direct versus astrocyte-mediated mechanisms. Brain Behav Immun 56:310\u2013324","journal-title":"Brain Behav Immun"},{"issue":"1","key":"5364_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-26915-2","volume":"8","author":"A Pallottie","year":"2018","unstructured":"Pallottie A, Ratnayake A, Ni L, Acioglu C, Li L, Mirabelli E et al (2018) A toll-like receptor 9 antagonist restores below-level glial glutamate transporter expression in the dorsal horn following spinal cord injury. Sci Rep 8(1):8723","journal-title":"Sci Rep"},{"key":"5364_CR85","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.nbd.2012.12.012","volume":"54","author":"BT David","year":"2013","unstructured":"David BT, Ratnayake A, Amarante MA, Reddy NP, Dong W, Sampath S et al (2013) A toll-like receptor 9 antagonist reduces pain hypersensitivity and the inflammatory response in spinal cord injury. Neurobiol Dis 54:194\u2013205","journal-title":"Neurobiol Dis"},{"issue":"21","key":"5364_CR86","doi-asserted-by":"publisher","first-page":"1800","DOI":"10.1089\/neu.2014.3357","volume":"31","author":"BT David","year":"2014","unstructured":"David BT, Sampath S, Dong W, Heiman A, Rella CE, Elkabes S et al (2014) A toll-like receptor 9 antagonist improves bladder function and white matter sparing in spinal cord injury. J Neurotrauma 31(21):1800\u20131806","journal-title":"J Neurotrauma"},{"issue":"1","key":"5364_CR87","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-08446-0","volume":"10","author":"V Bellver-Landete","year":"2019","unstructured":"Bellver-Landete V, Bretheau F, Mailhot B, Valli\u00e8res N, Lessard M, Janelle ME et al (2019) Microglia are an essential component of the neuroprotective scar that forms after spinal cord injury. Nat Commun 10(1):518","journal-title":"Nat Commun"},{"issue":"2","key":"5364_CR88","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0171003","volume":"12","author":"G Gucluler","year":"2017","unstructured":"Gucluler G, Adiguzel E, Gungor B, Kahraman T, Gursel M, Yilmaz B et al (2017) Impaired toll like receptor-7 and 9 induced immune activation in chronic spinal cord injured patients contributes to immune dysfunction. PLoS One 12(2):e0171003","journal-title":"PLoS One"},{"issue":"1","key":"5364_CR89","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-022-02482-2","volume":"19","author":"Z Qin","year":"2022","unstructured":"Qin Z, Song J, Lin A, Yang W, Zhang W, Zhong F et al (2022) GPR120 modulates epileptic seizure and neuroinflammation mediated by NLRP3 inflammasome. J Neuroinflammation 19(1):121","journal-title":"J Neuroinflammation"},{"issue":"4","key":"5364_CR90","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1111\/epi.13688","volume":"58","author":"A Gross","year":"2017","unstructured":"Gross A, Benninger F, Madar R, Illouz T, Griffioen K, Steiner I et al (2017) Toll-like receptor 3 deficiency decreases epileptogenesis in a pilocarpine model of SE-induced epilepsy in mice. Epilepsia 58(4):586\u2013596","journal-title":"Epilepsia"},{"issue":"2","key":"5364_CR91","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.nbd.2009.07.025","volume":"36","author":"MA Galic","year":"2009","unstructured":"Galic MA, Riazi K, Henderson AK, Tsutsui S, Pittman QJ (2009) Viral-like brain inflammation during development causes increased seizure susceptibility in adult rats. Neurobiol Dis 36(2):343\u2013351","journal-title":"Neurobiol Dis"},{"issue":"5","key":"5364_CR92","doi-asserted-by":"publisher","first-page":"3339","DOI":"10.4049\/jimmunol.175.5.3339","volume":"175","author":"HS Youn","year":"2005","unstructured":"Youn HS, Lee JY, Fitzgerald KA, Young HA, Akira S, Hwang DH (2005) Specific inhibition of MyD88-independent signaling pathways of TLR3 and TLR4 by resveratrol: molecular targets are TBK1 and RIP1 in TRIF complex. J Immunol 175(5):3339\u20133346","journal-title":"J Immunol"},{"issue":"8","key":"5364_CR93","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1007\/s11064-009-9920-0","volume":"34","author":"Z Wu","year":"2009","unstructured":"Wu Z, Xu Q, Zhang L, Kong D, Ma R, Wang L (2009) Protective effect of resveratrol against kainate-induced temporal lobe epilepsy in rats. Neurochem Res 34(8):1393\u20131400","journal-title":"Neurochem Res"},{"issue":"12","key":"5364_CR94","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1007\/s00011-019-01283-3","volume":"68","author":"AA Dombkowski","year":"2019","unstructured":"Dombkowski AA, Cukovic D, Bagla S, Jones M, Caruso JA, Chugani HT et al (2019) Tlr7 activation in epilepsy of tuberous sclerosis complex. Inflamm Res 68(12):993\u2013998","journal-title":"Inflamm Res"},{"issue":"6","key":"5364_CR95","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1038\/s12276-023-01000-5","volume":"55","author":"J Liu","year":"2023","unstructured":"Liu J, Ke P, Guo H, Gu J, Liu Y, Tian X et al (2023) Activation of TLR7-mediated autophagy increases epileptic susceptibility via reduced KIF5A-dependent GABAa receptor transport in a murine model. Exp Mol Med 55(6):1159\u20131173","journal-title":"Exp Mol Med"},{"issue":"1","key":"5364_CR96","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms7514","volume":"6","author":"T Matsuda","year":"2015","unstructured":"Matsuda T, Murao N, Katano Y, Juliandi B, Kohyama J, Akira S et al (2015) TLR9 signalling in microglia attenuates seizure-induced aberrant neurogenesis in the adult hippocampus. Nat Commun 6(1):6514","journal-title":"Nat Commun"},{"issue":"3","key":"5364_CR97","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.bj.2020.05.007","volume":"43","author":"MY Hsieh","year":"2020","unstructured":"Hsieh MY, Lin JJ, Hsia SH, Huang JL, Yeh KW, Chang KW et al (2020) Diminished toll-like receptor response in febrile infection-related epilepsy syndrome (FIRES). Biomed J 43(3):293\u2013304","journal-title":"Biomed J"},{"key":"5364_CR98","doi-asserted-by":"crossref","unstructured":"Sansing LH, Harris TH, Welsh FA, Kasner SE, Hunter CA, Kariko K (2011) Toll-like receptor 4 contributes to poor outcome after intracerebral hemorrhage. Ann Neurol 70(4):646\u2013656","DOI":"10.1002\/ana.22528"},{"key":"5364_CR99","doi-asserted-by":"crossref","unstructured":"McGeer PL, McGeer EG (2013) The amyloid cascade-inflammatory hypothesis of Alzheimer disease: implications for therapy. Acta Neuropathol\u00a0126(4):479-497","DOI":"10.1007\/s00401-013-1177-7"},{"issue":"12","key":"5364_CR100","doi-asserted-by":"publisher","first-page":"5380","DOI":"10.1038\/s41380-023-02166-0","volume":"28","author":"R Cacace","year":"2023","unstructured":"Cacace R, Zhou L, Hendrickx Van de Craen E, Buist A, Hoogmartens J, Sieben A (2023) Mutated Toll-like receptor 9 increases Alzheimer\u2019s disease risk by compromising innate immunity protection. Mol Psychiatry 28(12):5380\u20135389","journal-title":"Mol Psychiatry"},{"issue":"3","key":"5364_CR101","first-page":"229","volume":"15","author":"S Mortezagholi","year":"2016","unstructured":"Mortezagholi S, Babaloo Z, Rahimzadeh P, Ghaedi M, Namdari H, Assar S et al (2016) Evaluation of PBMC distribution and TLR9 expression in patients with systemic lupus erythematosus. Iran J Allergy Asthma Immunol 15(3):229\u2013236","journal-title":"Iran J Allergy Asthma Immunol"},{"issue":"4","key":"5364_CR102","first-page":"3247","volume":"17","author":"Y Yuan","year":"2019","unstructured":"Yuan Y, Zhao L, Ye Z, Ma H, Wang X, Jiang Z (2019) Association of toll-like receptor 9 expression with prognosis of systemic lupus erythematosus. Exp Ther Med 17(4):3247\u20133254","journal-title":"Exp Ther Med"},{"issue":"3","key":"5364_CR103","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1111\/jcmm.12456","volume":"19","author":"X Zhang","year":"2015","unstructured":"Zhang X, Ha T, Lu C, Lam F, Liu L, Schweitzer J et al (2015) Poly (I:C) therapy decreases cerebral ischaemia\/reperfusion injury via TLR3-mediated prevention of Fas\/FADD interaction. J Cell Mol Med 19(3):555\u2013565","journal-title":"J Cell Mol Med"},{"key":"5364_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109539","volume":"114","author":"W Shao","year":"2023","unstructured":"Shao W, Huang Y, Wang L, Li P, Jia Y, Zhang J (2023) Expression of fibrinogen-like protein 2 (Fgl2) on Toll-like receptor 9 (TLR9) expression in autoimmune myelitis. Int Immunopharmacol 114:109539","journal-title":"Int Immunopharmacol"},{"issue":"5","key":"5364_CR105","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.jaad.2003.11.066","volume":"50","author":"J Geisse","year":"2004","unstructured":"Geisse J, Caro I, Lindholm J, Golitz L, Stampone P, Owens M (2004) Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: results from two phase III, randomized, vehicle-controlled studies. J Am Acad Dermatol 50(5):722\u2013733","journal-title":"J Am Acad Dermatol"},{"issue":"21","key":"5364_CR106","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V124.21.3101.3101","volume":"124","author":"L Brenner","year":"2014","unstructured":"Brenner L, Arbeit RD, Sullivan T (2014) IMO-8400, an antagonist of toll-like receptors 7, 8, and 9, in development for genetically defined B-cell lymphomas: safety and activity in phase 1 and phase 2 clinical trials. Blood 124(21):3101","journal-title":"Blood"},{"issue":"3","key":"5364_CR107","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/s41375-020-0934-6","volume":"35","author":"HC Lantermans","year":"2021","unstructured":"Lantermans HC, Minderman M, Kuil A, Kersten MJ, Pals ST, Spaargaren M (2021) Identification of the SRC-family tyrosine kinase HCK as a therapeutic target in mantle cell lymphoma. Leukemia 35(3):881\u2013886","journal-title":"Leukemia"},{"issue":"11","key":"5364_CR108","doi-asserted-by":"publisher","first-page":"3285","DOI":"10.1172\/JCI25247","volume":"115","author":"JR Cirrito","year":"2005","unstructured":"Cirrito JR, Deane R, Fagan AM, Spinner ML, Parsadanian M, Finn MB et al (2005) P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model. J Clin Invest 115(11):3285\u20133290","journal-title":"J Clin Invest"},{"issue":"5","key":"5364_CR109","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1111\/j.1471-4159.2010.07002.x","volume":"115","author":"BV Zlokovic","year":"2010","unstructured":"Zlokovic BV, Deane R, Sagare AP, Bell RD, Winkler EA (2010) Low-density lipoprotein receptor-related protein-1: a serial clearance homeostatic mechanism controlling Alzheimer. J Neurochem 115(5):1077\u20131089","journal-title":"J Neurochem"},{"key":"5364_CR110","doi-asserted-by":"publisher","DOI":"10.1016\/j.addr.2022.114539","volume":"190","author":"J Wang","year":"2022","unstructured":"Wang J, Li Z, Pan M, Fiaz M, Hao Y, Yan Y et al (2022) Ultrasound-mediated blood-brain barrier opening: an effective drug delivery system for theranostics of brain diseases. Adv Drug Deliv Rev 190:114539","journal-title":"Adv Drug Deliv Rev"},{"key":"5364_CR111","doi-asserted-by":"crossref","unstructured":"Ramakrishna K, Viswanadh MK, Dumala N, Chakravarth G, Venkateswarlu K, Gutti G et al (2025) Advanced biomaterials in neuroprotection: innovations and clinical applications. In: Kumar G, Mukherjee S, Kumar S (eds) Biomaterials and neurodegenerative disorders. Springer, pp 69\u201392","DOI":"10.1007\/978-981-97-9959-6_4"},{"key":"5364_CR112","doi-asserted-by":"crossref","unstructured":"Ahmad SI (ed) (2012) Neurodegenerative diseases. Springer","DOI":"10.1007\/978-1-4614-0653-2"},{"key":"5364_CR113","doi-asserted-by":"crossref","unstructured":"Rai SN (ed) (2021) Recent advances in the treatment of neurodegenerative disorders. Bentham Science Publishers","DOI":"10.2174\/97816810877261210101"},{"issue":"4","key":"5364_CR114","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1016\/j.bbrc.2018.10.166","volume":"506","author":"Y Takeda","year":"2018","unstructured":"Takeda Y, Takaki H, Fukui-Miyazaki A, Yoshida S, Matsumoto M, Seya T (2018) Vaccine adjuvant ARNAX promotes mucosal IgA production in influenza HA vaccination. Biochem Biophys Res Commun 506(4):1019\u20131025","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"5364_CR115","doi-asserted-by":"publisher","DOI":"10.1186\/s13046-021-02017-2","volume":"40","author":"J De Waele","year":"2021","unstructured":"De Waele J, Verhezen T, van der Heijden S, Berneman ZN, Peeters M, Lardon F et al (2021) A systematic review on poly(I: C) and poly-ICLC in glioblastoma: adjuvants coordinating the unlocking of immunotherapy. J Exp Clin Cancer Res 40(1):213","journal-title":"J Exp Clin Cancer Res"},{"key":"5364_CR116","doi-asserted-by":"crossref","unstructured":"Chang SC, Zhang BX, Su EC, Wu WC, Hsieh TH, Salazar AM et al (2021) Hiltonol cocktail kills lung cancer cells by activating cancer-suppressors, PKR\/OAS, and restraining the tumor microenvironment. Int J Mol Sci\u00a022(4):1626","DOI":"10.3390\/ijms22041626"},{"issue":"8","key":"5364_CR117","doi-asserted-by":"publisher","first-page":"5200","DOI":"10.4049\/jimmunol.178.8.5200","volume":"178","author":"BB Gowen","year":"2007","unstructured":"Gowen BB, Wong MH, Jung KH, Sanders AB, Mitchell WM, Alexopoulou L et al (2007) TLR3 is essential for the induction of protective immunity against Punta Toro virus infection by the double-stranded RNA (dsRNA), poly(I:C12U), but not poly(I:C): differential recognition of synthetic dsRNA molecules. J Immunol 178(8):5200\u20135208","journal-title":"J Immunol"},{"issue":"2","key":"5364_CR118","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.virol.2009.05.013","volume":"390","author":"WL Chang","year":"2009","unstructured":"Chang WL, Barry PA, Szubin R, Wang D, Baumgarth N (2009) Human cytomegalovirus suppresses type I interferon secretion by plasmacytoid dendritic cells through its interleukin 10 homolog. Virology 390(2):330\u2013337","journal-title":"Virology"},{"issue":"1","key":"5364_CR119","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-11730-8","volume":"10","author":"C Song","year":"2019","unstructured":"Song C, Phuengkham H, Kim YS, Dinh VV, Lee I, Shin IW et al (2019) Syringeable immunotherapeutic nanogel reshapes tumor microenvironment and prevents tumor metastasis and recurrence. Nat Commun 10(1):3745","journal-title":"Nat Commun"},{"issue":"6","key":"5364_CR120","doi-asserted-by":"publisher","first-page":"1721","DOI":"10.1681\/ASN.2006101162","volume":"18","author":"RD Pawar","year":"2007","unstructured":"Pawar RD, Ramanjaneyulu A, Kulkarni OP, Lech M, Segerer S, Anders HJ (2007) Inhibition of toll-like receptor-7 (TLR-7) or TLR-7 plus TLR-9 attenuates glomerulonephritis and lung injury in experimental lupus. J Am Soc Nephrol 18(6):1721\u20131731","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"5364_CR121","doi-asserted-by":"publisher","first-page":"e815","DOI":"10.1093\/cid\/ciaa1534","volume":"72","author":"SA Riddler","year":"2021","unstructured":"Riddler SA, Para M, Benson CA, Mills A, Ramgopal M, DeJesus E et al (2021) Vesatolimod, a toll-like receptor 7 agonist, induces immune activation in virally suppressed adults living with human immunodeficiency virus-1. Clin Infect Dis 72(11):e815\u2013e824","journal-title":"Clin Infect Dis"},{"issue":"1","key":"5364_CR122","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-12657-w","volume":"10","author":"KA Michaelis","year":"2019","unstructured":"Michaelis KA, Norgard MA, Zhu X, Levasseur PR, Sivagnanam S, Liudahl SM et al (2019) The TLR7\/8 agonist R848 remodels tumor and host responses to promote survival in pancreatic cancer. Nat Commun 10(1):4682","journal-title":"Nat Commun"},{"key":"5364_CR123","doi-asserted-by":"publisher","DOI":"10.1016\/j.nano.2021.102415","volume":"37","author":"J Koh","year":"2021","unstructured":"Koh J, Kim S, Lee SN, Kim SY, Kim JE, Lee KY et al (2021) Therapeutic efficacy of cancer vaccine adjuvanted with nanoemulsion loaded with TLR7\/8 agonist in lung cancer model. Nanomedicine 37:102415","journal-title":"Nanomedicine"},{"issue":"5","key":"5364_CR124","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101036","volume":"4","author":"S Hawtin","year":"2023","unstructured":"Hawtin S, Andr\u00e9 C, Collignon-Zipfel G, Appenzeller S, Bannert B, Baumgartner L et al (2023) Preclinical characterization of the Toll-like receptor 7\/8 antagonist MHV370 for lupus therapy. Cell Rep Med 4(5):101036","journal-title":"Cell Rep Med"},{"key":"5364_CR125","doi-asserted-by":"crossref","unstructured":"He M, Soni B, Schwalie PC, H\u00fcsser T, Waltzinger C, De Silva D et al (2022) Combinations of toll-like receptor 8 agonist TL8-506 activate human tumor-derived dendritic cells. J Immunother Cancer\u00a010(6):e004268","DOI":"10.1136\/jitc-2021-004268"},{"issue":"2","key":"5364_CR126","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0008050","volume":"14","author":"SG Thacker","year":"2020","unstructured":"Thacker SG, McWilliams IL, Bonnet B, Halie L, Beaucage S, Rachuri S et al (2020) Cpg ODN D35 improves the response to abbreviated low-dose pentavalent antimonial treatment in non-human primate model of cutaneous leishmaniasis. PLoS Negl Trop Dis 14(2):e0008050","journal-title":"PLoS Negl Trop Dis"},{"issue":"8","key":"5364_CR127","doi-asserted-by":"publisher","first-page":"1996","DOI":"10.1158\/2159-8290.CD-20-1546","volume":"11","author":"C Haymaker","year":"2021","unstructured":"Haymaker C, Johnson DH, Murthy R, Bentebibel SE, Uemura MI, Hudgens CW et al (2021) Tilsotolimod with ipilimumab drives tumor responses in anti-PD-1 refractory melanoma. Cancer Discov 11(8):1996\u20132013","journal-title":"Cancer Discov"},{"key":"5364_CR128","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/978-1-4939-6445-1_2","volume":"1494","author":"JD Campbell","year":"2017","unstructured":"Campbell JD (2017) Development of the CpG adjuvant 1018: a case study. Methods Mol Biol 1494:15\u201327","journal-title":"Methods Mol Biol"},{"issue":"31","key":"5364_CR129","doi-asserted-by":"publisher","first-page":"48860","DOI":"10.18632\/oncotarget.10379","volume":"7","author":"Y Kitahata","year":"2016","unstructured":"Kitahata Y, Kanuma T, Hayashi M, Kobayashi N, Ozasa K, Kusakabe T et al (2016) Circulating nano-particulate TLR9 agonist scouts out tumor microenvironment to release immunogenic dead tumor cells. Oncotarget 7(31):48860\u201348869","journal-title":"Oncotarget"},{"issue":"5","key":"5364_CR130","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1191\/0961203306lu2299oa","volume":"15","author":"A Wozniacka","year":"2006","unstructured":"Wozniacka A, Lesiak A, Narbutt J, McCauliffe DP, Sysa-Jedrzejowska A (2006) Chloroquine treatment influences proinflammatory cytokine levels in systemic lupus erythematosus patients. Lupus 15(5):268\u2013275","journal-title":"Lupus"},{"issue":"5","key":"5364_CR131","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1111\/j.1365-2230.2008.03006.x","volume":"34","author":"A Lesiak","year":"2009","unstructured":"Lesiak A, Narbutt J, Kobos J, Kordek R, Sysa-Jedrzejowska A, Norval M et al (2009) Systematic administration of chloroquine in discoid lupus erythematosus reduces skin lesions via inhibition of angiogenesis. Clin Exp Dermatol 34(5):570\u2013575","journal-title":"Clin Exp Dermatol"},{"issue":"3","key":"5364_CR132","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1038\/cmi.2015.13","volume":"13","author":"Y Wu","year":"2016","unstructured":"Wu Y, He S, Bai B, Zhang L, Xue L, Lin Z et al (2016) Therapeutic effects of the artemisinin analog SM934 on lupus-prone MRL\/lpr mice via inhibition of TLR-triggered B-cell activation and plasma cell formation. Cell Mol Immunol 13(3):379\u2013390","journal-title":"Cell Mol Immunol"},{"issue":"2","key":"5364_CR133","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1002\/cpt.522","volume":"101","author":"E Monnet","year":"2017","unstructured":"Monnet E, Lapeyre G, Poelgeest EV, Jacqmin P, Graaf K, Reijers J et al (2017) Evidence of NI-0101 pharmacological activity, an anti-TLR4 antibody, in a randomized phase I dose escalation study in healthy volunteers receiving LPS. Clin Pharmacol Ther 101(2):200\u2013208","journal-title":"Clin Pharmacol Ther"},{"issue":"1","key":"5364_CR134","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1124\/mol.110.068064","volume":"79","author":"N Matsunaga","year":"2011","unstructured":"Matsunaga N, Tsuchimori N, Matsumoto T, Ii M (2011) TAK-242 (resatorvid), a small-molecule inhibitor of toll-like receptor (TLR) 4 signaling, binds selectively to TLR4 and interferes with interactions between TLR4 and its adaptor molecules. Mol Pharmacol 79(1):34\u201341","journal-title":"Mol Pharmacol"},{"issue":"3","key":"5364_CR135","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1177\/1352458508099141","volume":"15","author":"SA Broadley","year":"2009","unstructured":"Broadley SA, Vanags D, Williams B, Johnson B, Feeney D, Griffiths L et al (2009) Results of a phase IIa clinical trial of an anti-inflammatory molecule, chaperonin 10, in multiple sclerosis. Mult Scler 15(3):329\u2013336","journal-title":"Mult Scler"}],"container-title":["Molecular Neurobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05364-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12035-025-05364-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12035-025-05364-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T20:04:21Z","timestamp":1763409861000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12035-025-05364-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,15]]},"references-count":135,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["5364"],"URL":"https:\/\/doi.org\/10.1007\/s12035-025-05364-9","relation":{},"ISSN":["0893-7648","1559-1182"],"issn-type":[{"value":"0893-7648","type":"print"},{"value":"1559-1182","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,15]]},"assertion":[{"value":"11 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"54"}}